Skip to ContentSkip to Navigation
About us Medical Sciences Research Pediatrics
University Medical Center Groningen

New Key Publication: Taking One Step Back in Familial Hypercholesterolemia

31 January 2020

STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans

Objective: STAP1, encoding for STAP1 (signal transducing adaptor family member 1), has been reported as a candidate gene associated with familial hypercholesterolemia. Unlike established familial hypercholesterolemia genes, expression of STAP1 is absent in liver but mainly observed in immune cells. In this study, we set out to validate STAP1 as a familial hypercholesterolemia gene.

Approach and Results: A whole-body Stap1 knockout mouse model (Stap1−/−) was generated and characterized, without showing changes in plasma lipid levels compared with controls. In follow-up studies, bone marrow from Stap1−/− mice was transplanted to Ldlr−/− mice, which did not show significant changes in plasma lipid levels or atherosclerotic lesions. To functionally assess whether STAP1 expression in B cells can affect hepatic function, HepG2 cells were cocultured with peripheral blood mononuclear cells isolated from heterozygotes carriers of STAP1 variants and controls. The peripheral blood mononuclear cells from STAP1 variant carriers and controls showed similar LDLR mRNA and protein levels. Also, LDL (low-density lipoprotein) uptake by HepG2 cells did not differ upon coculturing with peripheral blood mononuclear cells isolated from either STAP1 variant carriers or controls. In addition, plasma lipid profiles of 39 carriers and 71 family controls showed no differences in plasma LDL cholesterol, HDL (high-density lipoprotein) cholesterol, triglycerides, and lipoprotein(a) levels. Similarly, B-cell populations did not differ in a group of 10 STAP1 variant carriers and 10 age- and sex-matched controls. Furthermore, recent data from UK Biobank do not show association between STAP1 rare gene variants and LDL cholesterol.

Conclusions: Our combined studies in mouse models and carriers of STAP1 variants indicate that STAP1 is not a familial hypercholesterolemia gene.


  • Natalia Loaiza
  • Merel L. Hartgers
  • Laurens F. Reeskamp
  • Jan-Willem Balder
  • Antoine Rimbert
  • Venetia Bazioti
  • Justina C. Wolters
  • Maaike Winkelmeijer
  • Hans P.G. Jansen
  • Geesje M. Dallinga-Thie
  • Andrea Volta
  • Nicolette Huijkman
  • Marieke Smit
  • Niels Kloosterhuis
  • Mirjam Koster
  • Arthur F. Svendsen
  • Bart van de Sluis
  • G. Kees Hovingh
  • Aldo Grefhorst
  • Jan Albert Kuivenhoven

  • Arteriosclerosis, Thrombosis, and Vascular Biology. ;0:ATVBAHA.119.313470

Last modified:31 January 2020 12.41 p.m.

More news

  • 01 July 2020

    Sander de Hosson elected Alumnus of the Year 2019

    Lung doctor Sander de Hosson has been elected Alumnus of the Year 2019 by the University of Groningen. He is receiving the award for the incisive way in which he calls for attention for the emotional side of palliative care and for making death a...

  • 01 July 2020

    Ymkje Anna de Vries wins Gratama Award

    The 2020 Gratama Science Award has been awarded to Dr Ymkje Anna de Vries of the Faculty of Behavioural and Social Sciences of the University of Groningen. De Vries followed degree programmes in the fields of neuroscience, clinical science and...

  • 01 July 2020

    Wierenga-Rengerink Dissertation Prize for Arpi Karapetian

    The Wierenga-Rengerink Dissertation Prize for the best PhD thesis of the year 2019 has been awarded to Dr Arpi Karapetian. Her 502-page thesis is entitled Bestuurdersaansprakelijkheid uit onrechtmatige daad: Civielrechtelijke en strafrechtelijke...